KORU Medical Systems, Inc. (NASDAQ:KRMD) Shares Sold by RBF Capital LLC

RBF Capital LLC lowered its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 34.7% in the third quarter, HoldingsChannel.com reports. The firm owned 521,319 shares of the company’s stock after selling 277,131 shares during the quarter. RBF Capital LLC’s holdings in KORU Medical Systems were worth $1,423,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Meros Investment Management LP boosted its stake in KORU Medical Systems by 20.7% in the second quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after acquiring an additional 137,918 shares in the last quarter. Vanguard Group Inc. boosted its stake in KORU Medical Systems by 2.7% in the first quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company’s stock valued at $4,630,000 after acquiring an additional 51,890 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in KORU Medical Systems in the second quarter valued at $107,000. Connor Clark & Lunn Investment Management Ltd. boosted its stake in KORU Medical Systems by 77.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after acquiring an additional 26,860 shares in the last quarter. Finally, Virtu Financial LLC acquired a new position in KORU Medical Systems in the first quarter valued at $63,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Craig Hallum upped their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Piper Sandler upped their price objective on shares of KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a research note on Thursday, November 14th. Finally, Canaccord Genuity Group increased their target price on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th.

KORU Medical Systems Stock Down 0.3 %

NASDAQ KRMD opened at $3.95 on Thursday. KORU Medical Systems, Inc. has a 52-week low of $1.98 and a 52-week high of $4.20. The firm has a 50-day moving average price of $2.97 and a 200 day moving average price of $2.61. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.